What Is ESMFold2?

ESMFold2 is part of Biohub's protein biology world model release. In that system, ESMC provides the protein language model foundation, ESMFold2 predicts all-atom structures, and ESM Atlas organizes large-scale predicted structures.

This site is a third-party guide and browser-local toolkit. It is not Biohub official, and it does not run hosted prediction in the free layer.

Official sources describe ESMFold2 as a model for predicting high-resolution all-atom 3D structures directly from amino acid sequences, with optional MSA support and examples that involve proteins plus biomolecular complexes.

For ligand-like examples, this site only follows officially supported examples and avoids claiming general small-molecule docking coverage.

The first release focuses on explanations, source links, starter code, input preparation, and confidence interpretation. Tools run in the browser and do not collect sequences, Biohub tokens, or prediction results.

Hosted prediction, sign-in, credits, queues, and result storage are Phase 2 features and require compliance work before launch.

The safest way to write about ESMFold2 is to separate official facts from reported claims. A fact such as the existence of the Biohub model page can be stated directly. A benchmark or comparison claim should be attributed to Biohub, Nature, or the paper source that makes it.

This distinction matters for a scientific SEO site. Users may arrive from broad searches such as "ESMFold2 accuracy" or "ESMFold2 vs AlphaFold3," but the page should avoid turning a sourced release claim into a universal benchmark conclusion.

When the official wording changes, the page should be updated rather than patched with vague language. The visible "Last updated" date is part of that editorial contract.

The older ESMFold name usually points to the ESM2-era single-sequence folding workflow. ESMFold2 is tied to the newer Biohub release, the ESMC foundation model, all-atom prediction workflows, and examples that include biomolecular complexes.

ESM3 is a separate generative model line, while ESM Atlas is a large-scale browsing and discovery resource. Keeping those names separate helps users avoid copying the wrong notebook, package import, or Hugging Face example.

If you are new to the model, start with this page and the Biohub source links. If you want implementation details, move to the GitHub and API guides. If you need a minimal scaffold, use the code generator and then verify the output against current official examples.

If your goal is online prediction, the Track A MVP does not run the model for you. Use official Biohub paths or a compliant local/serverless setup until the hosted prediction layer has biosafety, privacy, and billing controls.

Before treating any ESMFold2 page as implementation guidance, check three things: whether the source is official, whether the code path has a recent verification date, and whether the page is describing local tools or hosted prediction.

This first-release site is intentionally limited. It can help you understand terminology, generate a starter scaffold, and find official links, but it does not validate structures, benchmark model accuracy, or decide whether a predicted result is suitable for a biological conclusion.

That boundary is important for both users and search engines. A focused definition page should answer the search query quickly, then point to deeper pages for GitHub, API, comparisons, and source-specific details.

This launch page is written as a third-party guide, not as an official Biohub page. It links to Biohub, GitHub, Colab, model-card, paper, and reporting sources so readers can verify current details before copying code or making technical decisions.

The free Track A site does not collect protein sequences, private Biohub tokens, prediction outputs, or uploaded structure files. Browser-local tools can prepare starter code and examples, but hosted prediction, stored results, queues, and credits remain Phase 2 features.

Predicted structures should not be described as experimental validation, clinical evidence, or drug-development proof. When this page mentions model scope or comparisons, it keeps claims tied to official or clearly attributed sources.

If a source changes after this page is published, the source should win. The page should be updated with a new verification date instead of preserving stale client names, model IDs, pricing assumptions, or unsupported benchmark language.